Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Kura Oncology Reports Third Quarter 2024 Financial Results
-
CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
-
Jeff’s’ Brands Initiates Strategic Plan by Entering into a Non-Binding Letter of Intent to Sell Subsidiary to a U.S. Public Company at a valuation of approximately $13.125 million
-
Lifetime Brands, Inc. Reports Third Quarter 2024 Financial Results
-
Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024
-
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
-
RxSight, Inc. Reports Third Quarter 2024 Financial Results
-
CarGurus Announces Third Quarter 2024 Results
-
Robinhood Markets, Inc. to Present at the Wolfe Research Wealth Symposium on November 13, 2024
-
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
-
Nutanix Announces Date and Conference Call Information for First Quarter Fiscal Year 2025 Financial Results
-
Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations
-
AVITA Medical Reports Third Quarter Financial Results
-
PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028
-
Jennifer Lowry to Join the Board of Directors of TPI Composites, Inc.
-
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights
-
MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update
-
Green Thumb Industries Reports Third Quarter 2024 Results
-
Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update
-
Collegium Reports Record Third Quarter 2024 Financial Results
-
Sunrun Reports Third Quarter 2024 Financial Results
-
Travere Therapeutics Announces Proposed Public Offering of Common Stock
-
Verizon announces tender offers for six series of debt securities
-
Ascendis Pharma to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024
-
BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress
-
Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights
-
Senvest Capital Inc. Reports Results for the Third Quarter Ended September 30, 2024
-
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
-
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
-
Astec to participate in Baird’s 2024 Global Industrial Conference
-
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
-
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
-
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
-
Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM Portfolio
-
Gevo Reports Third Quarter 2024 Financial Results
-
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
-
Teknova Reports Third Quarter 2024 Financial Results
-
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024
-
Collegium Appoints Vikram Karnani as Chief Executive Officer
-
aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update
-
Research Frontiers Reports Third Quarter 2024 Financial Results and Will Host a Conference Call at 4:30p.m. Today
-
Nephros Announces Financial Results for Quarter Ended September 30, 2024
-
Axalta Celebrates the Opening of its Global Headquarters in the Philadelphia Navy Yard
-
authID Reports Financial and Operating Results for the Third Quarter Ended September 30, 2024
-
NV5 Announces Preliminary Unaudited Record Third Quarter Results
-
Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024
-
Quest Resource Holding Corporation Reports Third Quarter 2024 Financial Results
-
Vishay Intertechnology Declares Quarterly Dividend
-
Kratos Reports Third Quarter 2024 Financial Results
